Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ...
Novel score identifies the heart failure patients who benefit most from atrial fibrillation ablation
A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation ablation, according to late-breaking science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results